FDA

FDA Approval Positions Novartis in the Lead to Bring Oral MS Treatment to Market
Seeking Alpha
Mon, 06/14/10 - 12:05 pm
FDA
Novartis
MS
multiple sclerosis
Endologix gets FDA OK for stent line extension
Fri, 06/11/10 - 07:37 am
FDA
Endologix
stent grafts
Powerlink
FDA Panel Endorses Novartis Multiple Sclerosis Pill
Pharmalot
Thu, 06/10/10 - 08:38 pm
FDA
advisory panels
Novartis
MS
multiple sclerosis
Gilenia
How Pfizer's Pain Could Be Your Gain
Minyanville
Thu, 06/10/10 - 08:31 pm
Pfizer
FDA
warnings
Is The FDA Suppressing An Avandia Study?
Pharmalot
Thu, 06/10/10 - 01:05 pm
FDA
GSK
diabetes
Avandia
FDA warns Pfizer for unreported drug complaints
Yahoo/AP
Thu, 06/10/10 - 09:23 am
Pfizer
side effects
FDA
warning
FDA weighs benefits, risks of Novartis MS pill
Yahoo/AP
Tue, 06/8/10 - 06:57 pm
MS
FDA
multiple sclerosis
Gilenia
Depomed says FDA will review drug candidate
Yahoo/AP
Tue, 06/8/10 - 09:09 am
Depomed
FDA
postherpetic neuralgia
AstraZeneca Learns the FDA May Have Gotten Wise to Copy-Cat Drugs
BNET Pharma
Mon, 06/7/10 - 07:55 am
AstraZeneca
FDA
copycat drugs
RSV
Synagis
Rezield
FDA Panel for Arena Obesity Drug
Yahoo/Zacks.com
Thu, 06/3/10 - 08:54 pm
Arena Pharmaceuticals
obesity
FDA
advisory panels
Abbott Laboratories gets FDA approval for Architect HE4 blood test for ovarian cancer
Yahoo/AP
Thu, 06/3/10 - 08:48 pm
Abbott Laboratories
FDA
ovarian cancer
Architect HE4
KCI participating in FDA safety initiative
Thu, 06/3/10 - 12:44 pm
KCI
Kinetic Concepts
FDA
BD Announces First FDA-Cleared Assay on the BD MAX System to Detect Group B Streptococcus
Thu, 06/3/10 - 10:12 am
Becton Dickinson
FDA
GBS
FDA panel rejects AZ's new RSV drug in key setback
Fierce Biotech
Thu, 06/3/10 - 10:07 am
RSV
motavizumab
MedImmune
FDA
AstraZeneca
FDA orders new warning labels on GlaxoSmithKline asthma drugs Serevent, Advair
Bizjournals.com
Thu, 06/3/10 - 09:40 am
warnings
Serevent
GSK
FDA
asthma
Advair
Teva gets FDA approval for generic acne treatment
Yahoo/AP
Wed, 06/2/10 - 06:02 pm
Teva Pharmaceuticals
generics
FDA
acne
Galderma
Differin
Eisai’s Breast Cancer Drug Gets Priority Review
Bloomberg
Wed, 06/2/10 - 08:24 am
Eisai
FDA
breast cancer
Eribulin
Amgen Likely to React Dramatically to Early FDA Approval of Osteoporosis Drug
Seeking Alpha
Wed, 06/2/10 - 08:22 am
Amgen
Prolia
osteoporosis
FDA
FDA clears Amgen's bone-strengthening drug, Prolia
Yahoo/AP
Wed, 06/2/10 - 08:21 am
FDA
Prolia
Amgen
GSK
Merck
Zemeta
Fosamax
osteoporosis
Generic Drugmakers Lose Preemption Argument
Pharmalot
Tue, 06/1/10 - 06:04 am
generics
preemption
FDA
Teva Pharmaceuticals
Impax
Wyeth

Pages